{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:42:27Z","timestamp":1792669347543,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.oftale.2026.502657","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:31:18Z","timestamp":1791473478000},"page":"502657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in precision medicine for the anterior segment: therapeutic applications using CRISPR-Cas9"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2801-7988","authenticated-orcid":false,"given":"J.A.","family":"Le\u00f3n Agudelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.F.","family":"Le\u00f3n Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4136-3130","authenticated-orcid":false,"given":"M.C.","family":"Mart\u00ednez Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.V.","family":"V\u00e1squez Villamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Pacheco Ricardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Enr\u00edquez Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6213","key":"10.1016\/j.oftale.2026.502657_bib0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.oftale.2026.502657_bib0010","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.oftale.2026.502657_bib0015","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"J Cataract Refract Surg."},{"key":"10.1016\/j.oftale.2026.502657_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/srep23146","article-title":"Inhibition of HSV-1 replication by gene editing strategy","volume":"6","author":"Roehm","year":"2016","journal-title":"Sci Rep."},{"issue":"5","key":"10.1016\/j.oftale.2026.502657_bib0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","article-title":"Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice","volume":"39","author":"Yin","year":"2021","journal-title":"Nat Biotechnol."},{"issue":"1","key":"10.1016\/j.oftale.2026.502657_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16308-2","article-title":"Repair of the TGFBI gene in human corneal keratocytes derived from a granular corneal dystrophy patient via CRISPR\/Cas9-induced homology-directed repair","volume":"7","author":"Taketani","year":"2017","journal-title":"Sci Rep"},{"issue":"42","key":"10.1016\/j.oftale.2026.502657_bib0035","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9-based treatment of myocilin-associated glaucoma","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"10.1016\/j.oftale.2026.502657_bib0040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat Rev Genet."},{"issue":"7785","key":"10.1016\/j.oftale.2026.502657_bib0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature."},{"issue":"5819","key":"10.1016\/j.oftale.2026.502657_bib0050","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science."},{"issue":"1-2","key":"10.1016\/j.oftale.2026.502657_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2016.10.044","article-title":"CRISPR-based technologies for the manipulation of eukaryotic genomes","volume":"168","author":"Komor","year":"2017","journal-title":"Cell."},{"issue":"6299","key":"10.1016\/j.oftale.2026.502657_bib0060","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf5573","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science."},{"issue":"5","key":"10.1016\/j.oftale.2026.502657_bib0065","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ymthe.2017.03.008","article-title":"Taking stock of retinal gene therapy: looking back and moving forward","volume":"25","author":"Bennett","year":"2017","journal-title":"Mol Ther."},{"issue":"7546","key":"10.1016\/j.oftale.2026.502657_bib0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature."},{"key":"10.1016\/j.oftale.2026.502657_bib0075","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jconrel.2025.01.068","article-title":"Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye","volume":"379","author":"Vasudevan","year":"2025","journal-title":"J Control Release."},{"issue":"2","key":"10.1016\/j.oftale.2026.502657_bib0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat Med."},{"issue":"5","key":"10.1016\/j.oftale.2026.502657_bib0085","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv Ophthalmol."},{"issue":"1","key":"10.1016\/j.oftale.2026.502657_bib0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17936-5","article-title":"Gene editing and elimination of latent herpes simplex virus in vivo","volume":"11","author":"Aubert","year":"2020","journal-title":"Nat Commun."},{"issue":"6","key":"10.1016\/j.oftale.2026.502657_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005701","article-title":"CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections","volume":"12","author":"van Diemen","year":"2016","journal-title":"PLoS Pathog"},{"issue":"22","key":"10.1016\/j.oftale.2026.502657_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212346","article-title":"Control of HSV-1 infection: directions for the development of CRISPR\/Cas-based therapeutics and diagnostics","volume":"25","author":"Sosnovtseva","year":"2024","journal-title":"Int J Mol Sci."},{"issue":"5","key":"10.1016\/j.oftale.2026.502657_bib0105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable inhibition and detection of RNA viruses using Cas13","volume":"76","author":"Freije","year":"2019","journal-title":"Mol Cell."},{"key":"10.1016\/j.oftale.2026.502657_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1172-4-7","article-title":"Corneal dystrophies","volume":"4","author":"Klintworth","year":"2009","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.oftale.2026.502657_bib0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16279-4","article-title":"Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders","volume":"7","author":"Christie","year":"2017","journal-title":"Sci Rep."},{"issue":"5","key":"10.1016\/j.oftale.2026.502657_bib0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrg.2016.28","article-title":"Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases","volume":"17","author":"Tsai","year":"2016","journal-title":"Nat Rev Genet."},{"issue":"546","key":"10.1016\/j.oftale.2026.502657_bib0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9101","article-title":"In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness","volume":"12","author":"Yeh","year":"2020","journal-title":"Sci Transl Med."},{"issue":"4","key":"10.1016\/j.oftale.2026.502657_bib0130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.exer.2008.08.011","article-title":"Glaucoma-associated myocilin: a better understanding but much more to learn","volume":"88","author":"Resch","year":"2009","journal-title":"Exp Eye Res."},{"issue":"3","key":"10.1016\/j.oftale.2026.502657_bib0135","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbrc.2003.10.162","article-title":"Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells","volume":"312","author":"Joe","year":"2003","journal-title":"Biochem Biophys Res Commun."},{"issue":"5","key":"10.1016\/j.oftale.2026.502657_bib0140","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ophtha.2015.12.042","article-title":"Simple limbal epithelial transplantation: long-term clinical outcomes in 125 cases of unilateral chronic ocular surface burns","volume":"123","author":"Basu","year":"2016","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftale.2026.502657_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.matbio.2017.06.003","article-title":"Injury and defective regeneration of the epithelial basement membrane in corneal fibrosis: a paradigm for fibrosis in other organs?","volume":"64","author":"Wilson","year":"2017","journal-title":"Matrix Biol."},{"key":"10.1016\/j.oftale.2026.502657_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101482","article-title":"Nano-vectors for CRISPR\/Cas9-mediated genome editing","volume":"44","author":"Yang","year":"2022","journal-title":"Nano Today."},{"issue":"11","key":"10.1016\/j.oftale.2026.502657_bib0155","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.ymthe.2023.08.021","article-title":"In vivo CRISPR gene editing in patients with herpetic stromal keratitis","volume":"31","author":"Wei","year":"2023","journal-title":"Mol Ther."},{"key":"10.1016\/j.oftale.2026.502657_bib0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.879957","article-title":"From bench to bed: the current genome editing therapies for glaucoma","volume":"10","author":"He","year":"2022","journal-title":"Front Cell Dev Biol."},{"issue":"18","key":"10.1016\/j.oftale.2026.502657_bib0165","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.oftale.2026.502657_bib0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/bioengineering7030071","article-title":"Prospects and challenges of translational corneal bioprinting","volume":"7","author":"Fuest","year":"2020","journal-title":"Bioengineering (Basel)."},{"issue":"15","key":"10.1016\/j.oftale.2026.502657_bib0175","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"Raguram","year":"2022","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.oftale.2026.502657_bib0180","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/pharmaceutics14050998","article-title":"Ocular barriers and their influence on gene therapy products delivery","volume":"14","author":"Leclercq","year":"2022","journal-title":"Pharmaceutics."},{"issue":"7587","key":"10.1016\/j.oftale.2026.502657_bib0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.oftale.2026.502657_bib0190","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.oftale.2026.502657_bib0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1189\/jlb.1102574","article-title":"Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation","volume":"74","author":"Streilein","year":"2003","journal-title":"J Leukoc Biol."},{"issue":"3","key":"10.1016\/j.oftale.2026.502657_bib0200","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.exer.2003.09.008","article-title":"Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle","volume":"78","author":"Lavker","year":"2004","journal-title":"Exp Eye Res."},{"issue":"24","key":"10.1016\/j.oftale.2026.502657_bib0205","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1001\/jama.2018.18270","article-title":"The ethics of heritable genome editing: new considerations in a controversial area","volume":"320","author":"Adashi","year":"2018","journal-title":"JAMA."},{"issue":"6372","key":"10.1016\/j.oftale.2026.502657_bib0210","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.oftale.2026.502657_bib0215","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.exer.2018.05.010","article-title":"3D bioprinting of a corneal stroma equivalent","volume":"173","author":"Isaacson","year":"2018","journal-title":"Exp Eye Res."}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426002197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426002197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:10:52Z","timestamp":1792667452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579426002197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S2173579426002197"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502657","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in precision medicine for the anterior segment: therapeutic applications using CRISPR-Cas9","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2026.502657","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502657"}}